drugset / Trial / NCT01424397
Intranasal SB-705498 in Allergic Rhinitis (AR) Patients
RandomizedCrossoverDouble-blindTreatment
Summary
This study is designed to look at the affect of SB-705498 on allergic rhinitis symptoms induced by an allergen chamber challenge.
Timeline
- Start
- 2011-04-14
- Primary completion
- 2011-07-07
- Completion
- 2011-07-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluticasone propionate | Other / unclassified | 200 ug | Intranasal |
| Subject | SB-705498 | Small molecule | 12 mg | Intranasal |